Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder
This study has been completed.
Sponsors and Collaborators: UMC Utrecht
De Hersenstichting (The Dutch Brain Foundation)
Information provided by: UMC Utrecht
ClinicalTrials.gov Identifier: NCT00161161
  Purpose

Attention Deficit Hyperactivity Disorder (ADHD) is a heritable psychiatric disorder with onset in childhood. Twin and adoption studies indicate that additive genetic factors explain up to 80% of the variance underlying susceptibility. The siblings of children with ADHD have a three- to fivefold increased risk of having ADHD compared to the siblings of healthy control subjects, and the risk is even greater for monozygotic twins with 50-80% concordance compared with up to 33% in dizygotic twins). As full siblings share on average 50% of their genes, even the unaffected siblings of children with ADHD would be expected to share some of the genes involved in the disorder. The neuroanatomical substrate of ADHD is becoming increasingly better defined by a growing body of evidence from imaging studies. Evidence from neuroimaging studies suggests that this disorder is associated with reductions in brain volume up to 5% in these children. In this protocol we collected MRI-scans from boys with ADHD and their unaffected siblings, as well as control subjects. In addition, cheekswabs were later collected for DNA analysis.


Condition
Attention Deficit Hyperactivity Disorder

MedlinePlus related topics: Attention Deficit Hyperactivity Disorder
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Cross-Sectional, Case Control, Prospective Study
Official Title: Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder

Further study details as provided by UMC Utrecht:

Estimated Enrollment: 90
Study Start Date: October 1999
Estimated Study Completion Date: December 2002
  Eligibility

Ages Eligible for Study:   7 Years to 18 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. age 7 - 18 years.

Inclusion criteria for patients

  1. DSM-IV (APA, 1994) diagnosis of ADHD (combined subtype), according to DISC interview
  2. scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)
  3. one brother who meets the inclusion criteria for siblings

Inclusion criteria for siblings

  1. no DSM-IV (APA,1994) diagnosis for ADHD or another disruptive disorder (ODD or CD), according to DISC interview
  2. no scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)

Inclusion criteria for controls

  1. no DSM-IV (APA, 1994) diagnosis, according to DISC interview
  2. no scores in the clinical range on the Child Behavior Checklist (CBCL) and Teacher Rating Form (TRF)

Exclusion Criteria:

  1. IQ < 70
  2. illness of the cardiovascular, the endocrine, the pulmonal or the gastrointestinal system
  3. the presence of metal objects in or around the body (pacemaker, dental braces)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00161161

Locations
Netherlands
UMC Utrecht
Utrecht, Netherlands, 3584CX
Sponsors and Collaborators
UMC Utrecht
De Hersenstichting (The Dutch Brain Foundation)
Investigators
Principal Investigator: Sarah Durston, Ph.D. RMI of Neuroscience, UMC Utrecht
  More Information

Publications of Results:
Study ID Numbers: WOM 99/076
Study First Received: September 8, 2005
Last Updated: December 29, 2005
ClinicalTrials.gov Identifier: NCT00161161  
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by UMC Utrecht:
ADHD; MRI; genetics

Study placed in the following topic categories:
Signs and Symptoms
Attention Deficit Disorder with Hyperactivity
Mental Disorders
Mental Disorders Diagnosed in Childhood
Neurologic Manifestations
Attention Deficit and Disruptive Behavior Disorders
Hyperkinesis
Dyskinesias

Additional relevant MeSH terms:
Pathologic Processes
Disease
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009